Skip to main content
Signal8

Kung Winston

SEC insider (Form 3/4/5 filer). CIK 0001666963. Director at Janux Therapeutics, Inc. (JANX) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in NORWOOD, MA.

Companies Kung Winston has filed insider reports for

  • Janux Therapeutics, Inc. (JANX): Director
  • Corbus Pharmaceuticals Holdings, Inc. (CRBP): Director
  • ArriVent BioPharma, Inc. (AVBP): Officer, Chief Financial Officer
Kung Winston profile photo

Kung Winston

CIK: 0001666963

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (85.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Janux Therapeutics, Inc. logo
JANX

Janux Therapeutics, Inc.

Director
Corbus Pharmaceuticals Holdings, Inc. logo
CRBP

Corbus Pharmaceuticals Holdings, Inc.

Director
ArriVent BioPharma, Inc. logo
AVBP

ArriVent BioPharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Janux Therapeutics, Inc. logo
    JANX

    Janux Therapeutics, Inc.

    Jun 11, 2026
    Award
    Direct
    5.5K shares-
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    Jun 10, 2026
    Sale
    Direct
    2K shares at avg. $7.91$16K
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    May 19, 2026
    Award
    Direct
    3.8K shares-
  • ArriVent BioPharma, Inc. logo
    AVBP

    ArriVent BioPharma, Inc.

    Feb 2, 2026
    Award

    Stock Option (right to buy)

    Direct
    140K shares-
  • Janux Therapeutics, Inc. logo
    JANX

    Janux Therapeutics, Inc.

    Jun 11, 2025
    Award
    Direct
    3.8K shares-
  • Corbus Pharmaceuticals Holdings, Inc. logo
    CRBP

    Corbus Pharmaceuticals Holdings, Inc.

    May 30, 2025
    Award
    Direct
    4.8K shares-
  • ArriVent BioPharma, Inc. logo
    AVBP

    ArriVent BioPharma, Inc.

    Feb 3, 2025
    Award

    Stock Option (right to buy)

    Direct
    120K shares-

1-7 of 7